Navigate
X
    QualityStocks
  • 17 years ago

EntreMed, Inc. (NASDAQ: ENMD)

EntreMed, Inc. (NASDAQ: ENMD), a clinical-stage pharmaceutical company, develops therapeutic candidates mainly for the treatment of cancer and inflammation. The company has focused their efforts on developing drugs that are safe and convenient, and provide the potential for improved patient outcomes. EntreMed’s expertise lies in angiogenesis, cell cycle regulation, cell signaling and inflammation. For further information, visit the Company’s web site at www.entremed.com.

Tags Rodman & Renshaw
Related Post
  1. New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) Looks Forward to Bolivia Presidential Runoff, Hoping for Increased Foreign Investment Support

    Bolivia heads into an October presidential runoff, signaling a possible shift toward more pro-business policies,…

  2. Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF): Building Value Through Nevada’s Walker Lane

    Four-property portfolio in Nevada’s Walker Lane anchored by the Santa Fe Mine project with over…

  3. ONAR Holding Corp. (ONAR) Powers Smarter Marketing with Agency Innovation

    As budgets tighten and demands intensify, CMOs are questioning traditional marketing models ONAR is seizing…